GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...
In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the ...
MedPage Today on MSN
GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...
Techno-Science.net on MSN
Cannabis shows effectiveness against cancer
Scientists are examining the medicinal properties of cannabis, a plant often at the heart of debates. In the laboratory, ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
Diabetes medications found to influence cancer growth in unexpected ways What if the drugs millions take for diabetes every ...
A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may affect cancer growth.
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results